Effectiveness of mRNA COVID-19 Vaccines Against the Delta Variant
September 28, 2021
Slides - Effectiveness of mRNA COVID-19 Vaccines Against the Delta Variant
September 28, 2021
Slides - Effectiveness of mRNA COVID-19 Vaccines Against the Delta Variant
September, 2021
Abstract
We found no significant difference in cycle threshold values between vaccinated and unvaccinated, asymptomatic and symptomatic groups infected with SARS-CoV-2 Delta. Given the substantial proportion of asymptomatic vaccine breakthrough cases with high viral levels, interventions, including masking and testing, should be considered for all in settings with elevated COVID-19 transmission.
September, 2021
Abstract
Background Much research shows that blood calcidiol (25(OH)D3) levels correlate strongly with SARS-CoV-2 infection severity. There is open discussion regarding whether low D3 is caused by the infection or if deficiency negatively affects immune defense. The aim of this study was to collect further evidence on this topic.
September, 2021
Abstract
September, 2021
Highlights
• Bulk of COVID-19 per capita deaths occur in elderly with high comorbidities.
• Per capita COVID-19 deaths are negligible in children.
• Clinical trials for these inoculations were very short-term.
• Clinical trials did not address long-term effects most relevant to children.